울트라콜

Skip to content Skip to main menu

울트라콜

ULTRACOL is approved by
Korea's Ministry of Food and Drug Safety (MFDS)
and is intended to help temporarily improve
bilateral nasolabial folds on the face.

ULTRACOL

ULTRACOL is approved by
Korea's Ministry of Food and Drug Safety (MFDS)
and is intended to help temporarily improve
bilateral nasolabial folds on the face.

  • References 1, 2. Medical device manufacturing licence No. 3854-598
  • Reference 3. Validated based on data from patent application No. 10-2024-0040784

POINT.01

Class IV medical device — MFDS-approved product

POINT.02

Efficacy and safety demonstrated in clinical studies

POINT.03

Structural design that eases injection pressure

The world's first

PDO microsphere technology —
ULTRACOL's biodegradable polymer structure
based on PDO

ULTRACOL's PDO is built on biodegradable polymer materials.

Using in-house expertise aligned with the physical properties of PDO,
we developed a PDO-based polymer engineered for microparticle structures.

  • This section describes material characteristics and structure only.

PDO microparticle manufacturing technology
based on continuous reaction processes

Patents (Korea)
US patent
China patent
Japan patent

ULTRACOL is designed around a portfolio of domestic and international patents
covering biodegradable PDO-based microparticle manufacturing.

  • These technologies include patents on microparticle manufacturing, injectable formulations that incorporate them, and reactors for manufacturing.
  • Including Korean patent No. 10-1501217 and others.

Technical credibility validated
by accredited institutions

Built on proprietary PDO microparticle manufacturing technology,
ULTRACOL has been recognized for its technical capabilities
and quality management systems by accredited bodies in Korea and overseas.

Domestic patent certificate
Domestic recognition

ULTRACOL's PDO-based microparticle manufacturing technology, which applies continuous reaction processes, was recognized for its technical maturity and industrial value with the IR52 Jang Young-sil Award.

Certificate
Certificate
International certification

ULTRACOL has obtained CE marking after successfully completing conformity assessment under the EU Medical Device Regulation (MDR).

  • This page presents objective facts about technology and quality management only; it does not guarantee specific clinical outcomes or claim superiority over other products.
  • Certifications and awards reflect assessments of the product and/or manufacturing and quality management systems.

Global Network

36 Countries

From its roots in Asia across Europe and Latin America, ULTRACOL is established as a global brand in 36 countries worldwide.

FAQ

Find answers to common questions
about ULTRACOL

Which areas can be treated?

Treatment can be performed on various areas after consultation with a specialist.

How long does the procedure take?

The duration of the procedure may vary depending on the individual’s skin condition and the treatment area.

Will it affect daily activities?

You can generally resume your daily activities after the procedure.

Is the procedure painful?

The level of discomfort may vary depending on your individual skin condition.

Product inquiry

Send us your questions about ULTRACOL and our team will respond as soon as possible.

Captcha image
Full text